EP4392069A4 - Composition, son procédé de fabrication et ses utilisations - Google Patents

Composition, son procédé de fabrication et ses utilisations

Info

Publication number
EP4392069A4
EP4392069A4 EP22879031.7A EP22879031A EP4392069A4 EP 4392069 A4 EP4392069 A4 EP 4392069A4 EP 22879031 A EP22879031 A EP 22879031A EP 4392069 A4 EP4392069 A4 EP 4392069A4
Authority
EP
European Patent Office
Prior art keywords
preparing
composition
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP22879031.7A
Other languages
German (de)
English (en)
Other versions
EP4392069A2 (fr
Inventor
Choon Keong Lee
Giorgia Pastorin
Wei Jiang Goh
Wei Seong Toh
Shipin Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National University of Singapore
Original Assignee
National University of Singapore
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National University of Singapore filed Critical National University of Singapore
Publication of EP4392069A2 publication Critical patent/EP4392069A2/fr
Publication of EP4392069A4 publication Critical patent/EP4392069A4/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP22879031.7A 2021-10-08 2022-10-07 Composition, son procédé de fabrication et ses utilisations Pending EP4392069A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SG10202111225V 2021-10-08
PCT/SG2022/050720 WO2023059270A2 (fr) 2021-10-08 2022-10-07 Composition, son procédé de fabrication et ses utilisations

Publications (2)

Publication Number Publication Date
EP4392069A2 EP4392069A2 (fr) 2024-07-03
EP4392069A4 true EP4392069A4 (fr) 2025-08-06

Family

ID=85804836

Family Applications (1)

Application Number Title Priority Date Filing Date
EP22879031.7A Pending EP4392069A4 (fr) 2021-10-08 2022-10-07 Composition, son procédé de fabrication et ses utilisations

Country Status (2)

Country Link
EP (1) EP4392069A4 (fr)
WO (1) WO2023059270A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102023110270A1 (de) * 2023-04-21 2024-10-24 Universitätsklinikum Jena, Körperschaft des öffentlichen Rechts Verfahren zur Detektion und Quantifizierung von DNA-gebundenen Proteinen in Einzelzellen eines Zellgemisches

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013261037A1 (en) * 2012-05-17 2014-12-04 Contract Pharmaceuticals Limited Non-ionic vesicle formulations of calcium channel blockers
CN107753428A (zh) * 2016-08-23 2018-03-06 北京盈科瑞创新医药股份有限公司 阿达帕林囊泡及其制剂及制备方法
CN107320716B (zh) * 2017-06-27 2019-03-05 珠海亿胜生物制药有限公司 碱性成纤维细胞生长因子囊泡及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103169141B (zh) * 2013-03-18 2016-04-06 北京林业大学 一种利用类脂囊泡包封类胡萝卜素的制备方法

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013261037A1 (en) * 2012-05-17 2014-12-04 Contract Pharmaceuticals Limited Non-ionic vesicle formulations of calcium channel blockers
CN107753428A (zh) * 2016-08-23 2018-03-06 北京盈科瑞创新医药股份有限公司 阿达帕林囊泡及其制剂及制备方法
CN107320716B (zh) * 2017-06-27 2019-03-05 珠海亿胜生物制药有限公司 碱性成纤维细胞生长因子囊泡及其制备方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
RASOOL ALAA A ET AL: "Preparation and evaluation a proniosomal gel for terbutaline sulfate as transdermal drug delivery system", 30 June 2010 (2010-06-30), XP093284855, Retrieved from the Internet <URL:https://journal.uokufa.edu.iq/index.php/kjvs/article/view/4232/3889> [retrieved on 20250612] *

Also Published As

Publication number Publication date
EP4392069A2 (fr) 2024-07-03
WO2023059270A3 (fr) 2023-06-08
WO2023059270A2 (fr) 2023-04-13

Similar Documents

Publication Publication Date Title
EP3908562A4 (fr) Mousses céramiques, leurs procédés de fabrication et leurs utilisations
EP4317353A4 (fr) Composition de polissage, procédé de fabrication de composition de polissage et procédé de polissage
EP3823681A4 (fr) Pâte hémostatique et son procédé de fabrication
EP3810938C0 (fr) Élément de liaison et assemblage d&#39;éléments, et son procédé de fabrication
EP3733650C0 (fr) Procédé de préparation d&#39;un intermédiaire d&#39;élagolix et composition associée
EP4141080A4 (fr) Ensemble d&#39;agent adhésif, et corps mis en adhésion ainsi que procédé de fabrication de celui-ci
EP3760070C0 (fr) Gant et son procédé de production
EP4042842A4 (fr) Matériaux élaborés en poudres nanométriques, et procédé de fabrication et d&#39;utilisation desdits matériaux
EP4196175A4 (fr) Composés radiopharmaceutiques, leurs utilisations et leurs procédés de production
EP4318635A4 (fr) Électrolyte solide et son procédé de production
EP4359420A4 (fr) 25-hydroxy-cholest-5-en-3-sulfate choline, leurs procédés de préparation, et leurs utilisations
EP4005640A4 (fr) Produit cosmétique et méthode de production de produit cosmétique
EP3584298A4 (fr) Composition de polissage, son procédé de production et procédé de polissage utilisant la composition de polissage
EP4337653A4 (fr) Ligands de ciblage d&#39;arn, leurs compositions et procédés de fabrication et d&#39;utilisation associés
EP4294465A4 (fr) Compositions de parfum, leurs procédés de fabrication et articles les comprenant
EP4289785A4 (fr) Matériau, procédé de fabrication de matériau et matériau fonctionnel
EP3604368A4 (fr) Composition durcissable, son procédé de production et article l&#39;utilisant
EP4048230C0 (fr) Compositions orales de gliptine et leur procédé de préparation
EP4026856A4 (fr) Procédé de fabrication de perfluoroélastomère, et composition
EP4372054A4 (fr) Composition de silicone de type pâte, procédé de production associée, et produit cosmétique
EP4392069A4 (fr) Composition, son procédé de fabrication et ses utilisations
EP4155264A4 (fr) Composition, et procédé de fabrication de celle-ci
EP4269691A4 (fr) Article façonné moulé en pâte fibreuse et son procédé de fabrication
EP4139311A4 (fr) Cucurbituriles acycliques, leurs procédés de fabrication et leurs utilisations
EP4151120C0 (fr) Autocollant pour ongle et composition pour autocollant pour ongle et son procédé de préparation

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20240328

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20250704

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 47/12 20060101AFI20250630BHEP

Ipc: A61K 47/24 20060101ALI20250630BHEP

Ipc: A61K 31/4375 20060101ALI20250630BHEP

Ipc: A61K 8/14 20060101ALI20250630BHEP

Ipc: A61K 8/37 20060101ALI20250630BHEP

Ipc: A61K 8/92 20060101ALI20250630BHEP

Ipc: A61P 19/02 20060101ALI20250630BHEP

Ipc: A61K 9/00 20060101ALI20250630BHEP

Ipc: A61K 9/1272 20250101ALI20250630BHEP